Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms.
暂无分享，去创建一个
L. Leibovici | Y. Carmeli | D. Yahav | A. Skiada | G. Daikos | A. Antoniadou | J. Mouton | A. Nutman | M. Paul | L. Friberg | D. Iossa | E. Durante-Mangoni | M. Bernardo | D. Schwartz | S. Altunin | Yael Dishon Benattar | Y. Dickstein | Viktor Rognås | I. Deliolanis | Nadya Rakovitsky | Jonathan Lellouche | Vered Daitch